These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
543 related articles for article (PubMed ID: 25100063)
1. Resistance of ferroportin to hepcidin binding causes exocrine pancreatic failure and fatal iron overload. Altamura S; Kessler R; Gröne HJ; Gretz N; Hentze MW; Galy B; Muckenthaler MU Cell Metab; 2014 Aug; 20(2):359-67. PubMed ID: 25100063 [TBL] [Abstract][Full Text] [Related]
2. Hepcidin knockout mice spontaneously develop chronic pancreatitis owing to cytoplasmic iron overload in acinar cells. Lunova M; Schwarz P; Nuraldeen R; Levada K; Kuscuoglu D; Stützle M; Vujić Spasić M; Haybaeck J; Ruchala P; Jirsa M; Deschemin JC; Vaulont S; Trautwein C; Strnad P J Pathol; 2017 Jan; 241(1):104-114. PubMed ID: 27741349 [TBL] [Abstract][Full Text] [Related]
3. Disruption of the hepcidin/ferroportin regulatory circuitry causes low axial bone mass in mice. Ledesma-Colunga MG; Baschant U; Fiedler IAK; Busse B; Hofbauer LC; Muckenthaler MU; Altamura S; Rauner M Bone; 2020 Aug; 137():115400. PubMed ID: 32380257 [TBL] [Abstract][Full Text] [Related]
4. Disruption of the Hepcidin/Ferroportin Regulatory System Causes Pulmonary Iron Overload and Restrictive Lung Disease. Neves J; Leitz D; Kraut S; Brandenberger C; Agrawal R; Weissmann N; Mühlfeld C; Mall MA; Altamura S; Muckenthaler MU EBioMedicine; 2017 Jun; 20():230-239. PubMed ID: 28499927 [TBL] [Abstract][Full Text] [Related]
5. Mice with hepcidin-resistant ferroportin accumulate iron in the retina. Theurl M; Song D; Clark E; Sterling J; Grieco S; Altamura S; Galy B; Hentze M; Muckenthaler MU; Dunaief JL FASEB J; 2016 Feb; 30(2):813-23. PubMed ID: 26506980 [TBL] [Abstract][Full Text] [Related]
6. Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin. Aschemeyer S; Qiao B; Stefanova D; Valore EV; Sek AC; Ruwe TA; Vieth KR; Jung G; Casu C; Rivella S; Jormakka M; Mackenzie B; Ganz T; Nemeth E Blood; 2018 Feb; 131(8):899-910. PubMed ID: 29237594 [TBL] [Abstract][Full Text] [Related]
7. Targeting PKCα alleviates iron overload in diabetes and hemochromatosis through the inhibition of ferroportin. Banerjee S; Lu S; Jain A; Wang I; Tao H; Srinivasan S; Nemeth E; He P Blood; 2024 Sep; 144(13):1433-1444. PubMed ID: 38861671 [TBL] [Abstract][Full Text] [Related]
8. Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis. Nemeth E; Ganz T Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204327 [TBL] [Abstract][Full Text] [Related]
9. Ambient fine particulate matter aggravates atherosclerosis in apolipoprotein E knockout mice by iron overload via the hepcidin-ferroportin axis. Wan Q; Yang M; Liu Z; Wu J Life Sci; 2021 Jan; 264():118715. PubMed ID: 33160991 [TBL] [Abstract][Full Text] [Related]
10. Impact of D181V and A69T on the function of ferroportin as an iron export pump and hepcidin receptor. Praschberger R; Schranz M; Griffiths WJ; Baumgartner N; Hermann M; Lomas DJ; Pietrangelo A; Cox TM; Vogel W; Zoller H Biochim Biophys Acta; 2014 Sep; 1842(9):1406-12. PubMed ID: 24859227 [TBL] [Abstract][Full Text] [Related]
11. Physiological focus on the erythropoietin-hepcidin-ferroportin axis. D'Anna MC; Roque ME Can J Physiol Pharmacol; 2013 May; 91(5):338-45. PubMed ID: 23656253 [TBL] [Abstract][Full Text] [Related]
12. The iron-regulatory hormone hepcidin: a possible therapeutic target? Rochette L; Gudjoncik A; Guenancia C; Zeller M; Cottin Y; Vergely C Pharmacol Ther; 2015 Feb; 146():35-52. PubMed ID: 25205158 [TBL] [Abstract][Full Text] [Related]
14. Ferroportin diseases: functional studies, a link between genetic and clinical phenotype. Détivaud L; Island ML; Jouanolle AM; Ropert M; Bardou-Jacquet E; Le Lan C; Mosser A; Leroyer P; Deugnier Y; David V; Brissot P; Loréal O Hum Mutat; 2013 Nov; 34(11):1529-36. PubMed ID: 23943237 [TBL] [Abstract][Full Text] [Related]
15. Expression of hepcidin and ferroportin in full term placenta of pregnant cows. Roperto S; Russo V; Urraro C; Cutarelli A; Perillo A; De Falco F; Roperto F Theriogenology; 2017 Nov; 103():90-97. PubMed ID: 28780484 [TBL] [Abstract][Full Text] [Related]
16. Hepcidin induction limits mobilisation of splenic iron in a mouse model of secondary iron overload. Camberlein E; Abgueguen E; Fatih N; Canonne-Hergaux F; Leroyer P; Turlin B; Ropert M; Brissot P; Loréal O Biochim Biophys Acta; 2010 Mar; 1802(3):339-46. PubMed ID: 20045050 [TBL] [Abstract][Full Text] [Related]
17. Effect of ferroportin polymorphism on iron homeostasis and infection. Kasvosve I Clin Chim Acta; 2013 Feb; 416():20-5. PubMed ID: 23178444 [TBL] [Abstract][Full Text] [Related]
18. [Expression Changes of Hepcidin and Ferroportin 1 in Murine Model of Iron Overload]. Wang JW; Xu LH; Yao X; Fang JP Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):936-940. PubMed ID: 28641663 [TBL] [Abstract][Full Text] [Related]
19. Modelling Systemic Iron Regulation during Dietary Iron Overload and Acute Inflammation: Role of Hepcidin-Independent Mechanisms. Enculescu M; Metzendorf C; Sparla R; Hahnel M; Bode J; Muckenthaler MU; Legewie S PLoS Comput Biol; 2017 Jan; 13(1):e1005322. PubMed ID: 28068331 [TBL] [Abstract][Full Text] [Related]
20. Effects of iron overload condition on liver toxicity and hepcidin/ferroportin expression in thalassemic mice. Kumfu S; Chattipakorn SC; Fucharoen S; Chattipakorn N Life Sci; 2016 Apr; 150():15-23. PubMed ID: 26921633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]